| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 27,423 | 22,171 | 18,600 | 25,715 | | Cost of Revenue | 6,067 | 5,075 | 4,149 | 5,716 | | | Gross Profit | 21,356 | 17,096 | 14,451 | 19,999 | | | Operating Expenses | | Research Development | 4,227 | 3,396 | 3,320 | 3,095 | | Selling General and Administrative | 13,768 | 12,420 | 11,713 | 14,119 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 815 | 830 | 821 | 775 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,546 | 450 | (1,403) | 2,010 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 145 | 258 | 371 | 450 | | Earnings Before Interest And Taxes | 2,691 | 708 | (1,032) | 2,460 | | Interest Expense |
-
| 6 | 10 | 13 | | Income Before Tax | 2,691 | 702 | (1,042) | 2,447 | | Income Tax Expense | (6) | 69 | 75 | 179 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,697 | 633 | (1,117) | 2,268 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,697 | 633 | (1,117) | 2,268 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,697 | $633 | ($1,117) | $2,268 |
|
0.86% Nasdaq 
Income Statement
